Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phase III study--current status and problems].

S Negoro1, M Fukuoka

  • 1Dept. of Internal Medicine, Osaka Prefectural Habikino Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Identification of thymidylate synthase as a potential therapeutic target for lung cancer.

British journal of cancer·2025
Same author

Biomechanical comparison of titanium alloy additively manufactured and conventionally manufactured plate-screw constructs.

New Zealand veterinary journal·2023
Same author

Migratory bone lesions in lymphoma.

QJM : monthly journal of the Association of Physicians·2022
Same author

Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study.

Lung cancer (Amsterdam, Netherlands)·2020
Same author

The dynamics of granular flow from a silo with two symmetric openings.

Proceedings. Mathematical, physical, and engineering sciences·2019
Same author

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Phase III clinical trials are crucial for evaluating new treatments, comparing their effectiveness against standard therapies, and assessing safety. Proper study design, including endpoint selection and adequate patient sample size, ensures reliable results for new drug development.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Biostatistics

Context:

  • Phase III studies represent the final stage of drug evaluation before regulatory approval.
  • These trials are designed to rigorously assess the efficacy and safety of novel therapeutic interventions.
  • They are typically conducted in a prospective, randomized, and disease-specific manner.

Purpose:

  • To compare a new treatment against the natural progression of a disease.
  • To determine if a new treatment is superior to existing standard therapies.
  • To ascertain if a new treatment offers comparable efficacy to standard therapy with reduced toxicity.

Summary:

  • This paper details the design principles for Phase III clinical trials.
  • Key considerations include the selection of appropriate endpoints such as tumor response, survival rates, toxicity profiles, and quality of life.

Related Experiment Videos

  • Crucially, determining the necessary patient sample size, based on expected treatment differences, is emphasized to ensure statistical power and prevent uninterpretable results.

    • Impact:

    • Provides a foundational guide for designing robust Phase III studies.
    • Highlights the critical role of sample size calculation in achieving definitive clinical trial outcomes.
    • Aims to improve the reliability and interpretability of evidence generated for new drug and treatment evaluations.